The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 29, 2025
Filed:
Nov. 08, 2023
Applicant:
Aclaris Therapeutics, Inc., Wayne, PA (US);
Inventors:
Walter Smith, St. Louis, MO (US);
Joseph Monahan, Eureka, MO (US);
Edward Hellriegel, Barto, PA (US);
David Gordon, Ardmore, PA (US);
Heidi Hope, St. Louis, MO (US);
John Robert Springer, Wentzville, MO (US);
Gary A. Decrescenzo, Parkville, MO (US);
Assignee:
Aclaris Therapeutics, Inc., Wayne, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); A61P 31/14 (2006.01); A61P 37/06 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 9/0053 (2013.01); A61K 9/20 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); A61P 31/14 (2018.01); A61P 37/06 (2018.01); C07D 401/14 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present disclosure relates to oral compositions of Compound I or a derivative thereof. Methods of use for treating an inflammatory condition are also disclosed.